ArticleOncoimmunology
Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma.
Shiro Suzuki et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
28 papers cite it
pooled ittrialcites it